294 related articles for article (PubMed ID: 26351937)
1. mRNA overexpression of kallikrein-related peptidase 14 (KLK14) is an independent predictor of poor overall survival in chronic lymphocytic leukemia patients.
Kontos CK; Adamopoulos PG; Papageorgiou SG; Pappa V; Scorilas A
Clin Chem Lab Med; 2016 Feb; 54(2):315-24. PubMed ID: 26351937
[TBL] [Abstract][Full Text] [Related]
2. KLKB1 mRNA overexpression: A novel molecular biomarker for the diagnosis of chronic lymphocytic leukemia.
Adamopoulos PG; Kontos CK; Papageorgiou SG; Pappa V; Scorilas A
Clin Biochem; 2015 Sep; 48(13-14):849-54. PubMed ID: 25891023
[TBL] [Abstract][Full Text] [Related]
3. Parallel overexpression and clinical significance of kallikrein-related peptidases 7 and 14 (KLK7KLK14) in colon cancer.
Devetzi M; Trangas T; Scorilas A; Xynopoulos D; Talieri M
Thromb Haemost; 2013 Apr; 109(4):716-25. PubMed ID: 23224034
[TBL] [Abstract][Full Text] [Related]
4. mRNA overexpression of the hypoxia inducible factor 1 alpha subunit gene (HIF1A): An independent predictor of poor overall survival in chronic lymphocytic leukemia.
Kontos CK; Papageorgiou SG; Diamantopoulos MA; Scorilas A; Bazani E; Vasilatou D; Gkontopoulos K; Glezou E; Stavroulaki G; Dimitriadis G; Pappa V
Leuk Res; 2017 Feb; 53():65-73. PubMed ID: 28038356
[TBL] [Abstract][Full Text] [Related]
5. Elevated miR-20b-5p expression in peripheral blood mononuclear cells: A novel, independent molecular biomarker of favorable prognosis in chronic lymphocytic leukemia.
Papageorgiou SG; Kontos CK; Tsiakanikas P; Stavroulaki G; Bouchla A; Vasilatou D; Bazani E; Lazarakou A; Scorilas A; Pappa V
Leuk Res; 2018 Jul; 70():1-7. PubMed ID: 29715621
[TBL] [Abstract][Full Text] [Related]
6. A novel, mitochondrial, internal tRNA-derived RNA fragment possesses clinical utility as a molecular prognostic biomarker in chronic lymphocytic leukemia.
Karousi P; Adamopoulos PG; Papageorgiou SG; Pappa V; Scorilas A; Kontos CK
Clin Biochem; 2020 Nov; 85():20-26. PubMed ID: 32745483
[TBL] [Abstract][Full Text] [Related]
7. High expression of KLK14 in prostatic adenocarcinoma is associated with elevated risk of prostate-specific antigen relapse.
Rabien A; Fritzsche F; Jung M; Diamandis EP; Loening SA; Dietel M; Jung K; Stephan C; Kristiansen G
Tumour Biol; 2008; 29(1):1-8. PubMed ID: 18497543
[TBL] [Abstract][Full Text] [Related]
8. Advanced high-grade serous ovarian cancer: inverse association of KLK13 and KLK14 mRNA levels in tumor tissue and patients' prognosis.
Dettmar L; Ahmed N; Kotzsch M; Diersch S; Napieralski R; Darmoul D; Schmitt M; Weichert W; Kiechle M; Dorn J; Magdolen V
J Cancer Res Clin Oncol; 2018 Jun; 144(6):1109-1118. PubMed ID: 29546479
[TBL] [Abstract][Full Text] [Related]
9. Angiopoietin-2 mRNA expression is increased in chronic lymphocytic leukemia patients with poor prognostic features.
Vrbacky F; Smolej L; Vroblova V; Pekova S; Hrudkova M; Cervinka M; Pecka M; Krejsek J; Maly J
Hematology; 2010 Aug; 15(4):210-4. PubMed ID: 20670479
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-92a-3p overexpression in peripheral blood mononuclear cells is an independent predictor of prolonged overall survival of patients with chronic lymphocytic leukemia.
Papageorgiou SG; Diamantopoulos MA; Kontos CK; Bouchla A; Vasilatou D; Bazani E; Scorilas A; Pappa V
Leuk Lymphoma; 2019 Mar; 60(3):658-667. PubMed ID: 29911923
[TBL] [Abstract][Full Text] [Related]
11. Clinical relevance of the deregulated kallikrein-related peptidase 8 mRNA expression in breast cancer: a novel independent indicator of disease-free survival.
Michaelidou K; Ardavanis A; Scorilas A
Breast Cancer Res Treat; 2015 Jul; 152(2):323-36. PubMed ID: 26099606
[TBL] [Abstract][Full Text] [Related]
12. Integrated CLL Scoring System, a New and Simple Index to Predict Time to Treatment and Overall Survival in Patients With Chronic Lymphocytic Leukemia.
Visentin A; Facco M; Frezzato F; Castelli M; Trimarco V; Martini V; Gattazzo C; Severin F; Chiodin G; Martines A; Bonaldi L; Gianesello I; Pagnin E; Boscaro E; Piazza F; Zambello R; Semenzato G; Trentin L
Clin Lymphoma Myeloma Leuk; 2015 Oct; 15(10):612-20.e1-5. PubMed ID: 26233718
[TBL] [Abstract][Full Text] [Related]
13. Quantitative analysis of human kallikrein gene 14 expression in breast tumours indicates association with poor prognosis.
Yousef GM; Borgoño CA; Scorilas A; Ponzone R; Biglia N; Iskander L; Polymeris ME; Roagna R; Sismondi P; Diamandis EP
Br J Cancer; 2002 Nov; 87(11):1287-93. PubMed ID: 12439719
[TBL] [Abstract][Full Text] [Related]
14. FCRL2 mRNA expression is inversely associated with clinical progression in chronic lymphocytic leukemia.
Nückel H; Collins CH; Frey UH; Sellmann L; Dürig J; Siffert W; Dührsen U
Eur J Haematol; 2009 Dec; 83(6):541-9. PubMed ID: 19682311
[TBL] [Abstract][Full Text] [Related]
15. Identification of a novel, internal tRNA-derived RNA fragment as a new prognostic and screening biomarker in chronic lymphocytic leukemia, using an innovative quantitative real-time PCR assay.
Katsaraki K; Artemaki PI; Papageorgiou SG; Pappa V; Scorilas A; Kontos CK
Leuk Res; 2019 Dec; 87():106234. PubMed ID: 31669784
[TBL] [Abstract][Full Text] [Related]
16. The novel member of the BCL2 gene family, BCL2L12, is substantially elevated in chronic lymphocytic leukemia patients, supporting its value as a significant biomarker.
Papageorgiou SG; Kontos CK; Pappa V; Thomadaki H; Kontsioti F; Dervenoulas J; Papageorgiou E; Economopoulos T; Scorilas A
Oncologist; 2011; 16(9):1280-91. PubMed ID: 21737576
[TBL] [Abstract][Full Text] [Related]
17. Low mRNA expression levels of kallikrein-related peptidase 4 (KLK4) predict short-term relapse in patients with laryngeal squamous cell carcinoma.
Foteinou E; Kontos CK; Giotakis AI; Scorilas A
Biol Chem; 2014 Sep; 395(9):1051-62. PubMed ID: 24854539
[TBL] [Abstract][Full Text] [Related]
18. Analysis of LPL gene expression in patients with chronic lymphocytic leukemia.
Bilous N; Abramenko I; Chumak A; Dyagil I; Martina Z
Exp Oncol; 2019 Mar; 41(1):39-45. PubMed ID: 30932419
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-155-5p Overexpression in Peripheral Blood Mononuclear Cells of Chronic Lymphocytic Leukemia Patients Is a Novel, Independent Molecular Biomarker of Poor Prognosis.
Papageorgiou SG; Kontos CK; Diamantopoulos MA; Bouchla A; Glezou E; Bazani E; Pappa V; Scorilas A
Dis Markers; 2017; 2017():2046545. PubMed ID: 29463948
[TBL] [Abstract][Full Text] [Related]
20. Quantification of ZAP70 mRNA in B cells by real-time PCR is a powerful prognostic factor in chronic lymphocytic leukemia.
Stamatopoulos B; Meuleman N; Haibe-Kains B; Duvillier H; Massy M; Martiat P; Bron D; Lagneaux L
Clin Chem; 2007 Oct; 53(10):1757-66. PubMed ID: 17702857
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]